KN046 in Subjects With Advanced Solid Tumors and Lymphoma
Clinical trial NCT03733951 · COMPLETED
Trial details
- NCT number
- NCT03733951
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2023-01-03
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.